Occlusion Devices Market Size, Share, Analysis, Trends, Growth, Forecasts 2032

The global Occlusion Devices market size accrued earnings worth approximately USD 3.21 Billion in 2023 and is predicted to gain revenue of about USD 5.25 Billion by 2032, is set to record a CAGR of nearly 5.62% over the period from 2024 to 2032. The study includes drivers and restraints of the occlusion devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the occlusion devices market on a global as well as regional level.

Request Free Sample

In order to give the users of this report a comprehensive view of the occlusion devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the occlusion devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the occlusion devices market on a global and regional basis.

Occlusion devices are commonly used in cardiology for correcting the conditions caused by blood flow blockages in coronary arteries. In terms of medical expression, occlusion means a closed blood vessel or hollow organ. Therefore, to treat heart blockages, cardiovascular defects, and neurological defects, a wide range of dissimilar occlusion devices are used. Cardiac occlusion devices help to reduce the risk of open-heart surgeries. Thus, these medical devices have emerged as a more effective choice than anti-coagulation therapy in treating strokes caused by atrial fibrillation. The demand for occlusion devices is increasing due to their effectiveness, safety, and cost-effectiveness. Additionally, more patients are using occlusion devices to reduce the risk of embolic strokes as compared to anticoagulant therapy. Occlusion devices form a vital element of the interventional strategy for the closure of the left atrial appendage.

The global occlusion devices market is growing at a rapid pace in the global healthcare market due to the increasing prevalence of heart-related issues, such as cardiology and peripheral vascular disease, growing target patient population, and a huge demand for diagnostic treatment and procedures. Additionally, favorable compensation policies, increasing availability of medical reimbursements for occlusion devices, and accessibility of clinical support for efficiency and safety of occlusion methods are some other factors driving the global occlusion devices market. Moreover, the growing accessibility of diagnostic services for different chronic diseases, continuous product launches by key manufacturers, rising adoption of minimally-invasive surgical procedures, and technological advancements are also important aspects contributing to the occlusion devices market across the globe. However, procedural limitations related to CTO treatments, a strict regulatory framework for product commercialization, and lack of skilled surgeons may limit the global occlusion devices market. Alternatively, increasing government initiative for developing healthcare infrastructure in emerging markets is likely to provide ample growth opportunities for the occlusion devices market.

Request Free Sample

Occlusion Devices Market: Report Scope

Occlusion Devices Market: Segmentation Analysis

The study provides a decisive view of the occlusion devices market by segmenting it based on the product, end-user, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

The product segment includes embolization devices, support devices, and occlusion removal devices. Occlusion removal devices are further divided into balloon occlusion devices, suction and aspiration devices, stent retrievers, and coil retrievers. Embolization devices are sub-categorized into liquid embolic agents and tubal occlusion devices. Furthermore, support devices are bifurcated into microcatheters and guidewires.

Based on end-user, the market is categorized into hospitals and clinics, surgical centers, diagnostic centers, ambulatory care centers, and others.

By application, the market includes neurology, gynecology, cardiology, urology, peripheral vascular disease, oncology, and others. The neurology segment is dominating the market with the largest revenue share.

Occlusion Devices Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Occlusion Devices Market: Competitive Players

Some key players operating in the global occlusion devices market are

• Abbott Laboratories
• AngioDynamics
• Cardinal Health
• Avinger
• Asahi Intecc
• Edwards Lifesciences
• Stryker Corporation
• Penumbra
• Cook Group
• B. Braun Melsungen
• Medtronic
• Terumo Corporation
• Terumo Corporation
• Meril Life Sciences
• Biosensors International
• MicroPort Scientific
• Elixir Medical
• Kyoto Medical Planning
• and Boston Scientific

This report segments the global occlusion devices market into:

Global Occlusion Devices Market: By Product

• Occlusion Removal Devices

• Balloon Occlusion Devices
• Suction and Aspiration Devices
• Stent Retrievers
• Coil Retrievers

• Embolization Devices

• Liquid Embolic Agents
• Tubal Occlusion Devices

• Support Devices

• Microcatheters
• Guidewires

Global Occlusion Devices Market: By End-User

• Clinics and Hospitals
• Diagnostic Centers
• Surgical Centers
• Ambulatory Care Centers
• Others

Global Occlusion Devices Market: By Application

• Neurology
• Gynecology
• Cardiology
• Urology
• Peripheral Vascular Diseases
• Oncology
• Others

Global Occlusion Devices Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa